USCWA
SRNE

U.S. Capital Wealth Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-325
Closed -$288 – 1614
2022
Q4 		$288 Buy
+325
New +$288 ﹤0.01% 1593